Point72 Asset Management, L.P. 13D/13G Filings for X4 Pharmaceuticals, Inc. (XFOR)

Point72 Asset Management, L.P. 13D and 13G filings for X4 Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-02-14
4:18 pm
Sale		 2022-12-31 13G X4 Pharmaceuticals, Inc.
XFOR		 Point72 Asset Management, L.P. 30,441
1.300%		 -23,999decrease
(-44.08%)		 Filing
2022-02-14
4:38 pm
Purchase		 2021-12-31 13G X4 Pharmaceuticals, Inc.
XFOR		 Point72 Asset Management, L.P. 54,440
5.800%		 4,432increase
(+8.86%)		 Filing
2021-11-17
5:27 pm
Purchase		 2021-11-09 13G X4 Pharmaceuticals, Inc.
XFOR		 Point72 Asset Management, L.P. 50,008
5.600%		 50,008increase
(New Position)		 Filing